NexgenRx Inc. (TSXV:NXG)

NexgenRx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.57	4.78	1.71	1.88	1.77	2.32
Cash & Short-Term Investments	3.57	4.78	1.71	1.88	1.77	2.32
Cash Growth	67.18%	180.05%	-9.12%	6.22%	-23.74%	188.92%
Accounts Receivable	3.38	0.73	0.82	0.73	0.41	0.48
Receivables	3.38	0.73	0.87	0.78	0.41	0.48
Prepaid Expenses	0.22	0.27	0.27	0.27	0.29	0.16
Other Current Assets	34.73	26.63	21.8	20.42	15.54	17.87
Total Current Assets	41.9	32.4	24.65	23.34	18	20.83
Property, Plant & Equipment	0.83	0.8	0.83	0.81	0.84	0.5
Goodwill	1.08	1.08	1.24	1.24	1.24	1.24
Other Intangible Assets	1.13	1.4	2.33	3.15	4.1	5.12
Long-Term Deferred Tax Assets	0.56	0.51	1.15	1.51	1.52	1.7
Other Long-Term Assets	0.51	0.41	0.23	0.04	0.04	0.04
Total Assets	46	36.6	30.46	30.2	25.75	29.44

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.6	1.98	0.5	1.18	0.92	1.41
Current Portion of Leases	0.03	0.08	0.11	0.06	0.04	0.23
Other Current Liabilities	34.73	26.63	21.8	20.84	15.54	17.91
Total Current Liabilities	36.36	28.69	22.41	22.08	16.51	19.55
Long-Term Leases	0.25	0.29	0.43	0.4	0.39	0.17
Total Liabilities	36.61	28.98	22.84	22.48	16.9	19.72

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.01	4.01	4.01	3.82	19.29	19.29
Additional Paid-In Capital	4.4	4.4	4.39	4.38	4.35	4.3
Retained Earnings	-0.67	-2.44	-2.43	-2.14	-16.43	-15.53
Total Common Equity	7.74	5.97	5.97	6.06	7.2	8.06
Shareholders' Equity	9.39	7.62	7.62	7.71	8.85	9.71
Total Liabilities & Equity	46	36.6	30.46	30.2	25.75	29.44

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.28	0.37	0.53	0.46	0.43	0.4
Net Cash (Debt)	3.29	4.41	1.17	1.41	1.33	1.92
Net Cash Growth	93.80%	276.44%	-17.18%	6.03%	-30.33%	-
Net Cash Per Share	0.04	0.06	0.02	0.02	0.02	0.03
Filing Date Shares Outstanding	71.12	71.12	71.12	70.53	70.34	70.34
Total Common Shares Outstanding	71.12	71.12	71.12	70.53	70.34	70.34
Working Capital	5.54	3.71	2.24	1.26	1.5	1.28
Book Value Per Share	0.11	0.08	0.08	0.09	0.10	0.11
Tangible Book Value	5.53	3.49	2.41	1.68	1.86	1.71
Tangible Book Value Per Share	0.08	0.05	0.03	0.02	0.03	0.02
Machinery	1.42	1.22	0.96	0.91	0.84	0.74
Leasehold Improvements	0.22	0.22	0.22	0.22	0.21	0.36

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error